Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Targeting tumors: Ion beam accelerators take aim at cancer

12.02.2014
AAAS symposium and press briefing to explore the physics, biology, and clinical use of advanced particle therapy cancer treatments and related economic and ethical issues

EVENT: Advances in the design and operation of particle accelerators built for basic physics research are leading to the rapid evolution of machines that deliver cancer-killing beams. Hear about the latest developments and challenges in this field from a physicist, a radiobiologist, and a clinical oncologist, and participate in a discussion about cost, access, and ethics at a symposium organized by the U.S. Department of Energy's Brookhaven National Laboratory ("Targeting Tumors: Ion Beam Accelerators Take Aim at Cancer") and at a related press briefing--both to be held at the 2014 meeting of the American Association for the Advancement of Science.

WHEN: Sunday, February 16, 2014, 8:00 a.m. Central Time (symposium) and 11:00 a.m. (press briefing)

WHERE: Symposium: Hyatt Regency Chicago, Grand Ballroom A; Press Briefing: Swissotel, AAAS briefing room, adjacent to the newsroom, second floor.

WEBCAST: For reporters unable to attend the meeting, the press briefing portion will be webcast live and archived in the AAAS meeting newsroom.

DETAILS: As particle accelerator technology has been incorporated into the clinical practice of treating cancer, the trend has been toward less expensive, more versatile particle beam delivery systems, designed for improved efficacy and greater access for cancer patients around the world. Proton and ion beams are particularly attractive in treating cancer because they deposit most of their energy where the beam stops (i.e., in the tumor) rather than in the tissue through which they travel. As a result, particle beams can deliver cell-killing energy with extreme precision, allowing less damage to adjacent healthy tissue than conventional x-ray or electron radiation treatments.

Protons have been in use for some time at several facilities in the U.S. Beams of heavier ions such as carbon offer promise of even greater efficacy, based on the physics and expected radiobiological effects, as well as on preliminary evidence from facilities operating in Europe and Japan. There are currently no carbon therapy cancer treatment facilities operating in the U.S., and while experience from Europe and Asia suggests that the cost of building one would be considerable, the U.S. National Cancer Institute recently announced a funding opportunity to encourage and support plans for a center for particle beam radiation therapy research.

This symposium and press briefing will explore the scientific rationale behind hadron beam therapy (using protons and heavier ions such as carbon) from the perspectives of a physicist who designs state-of-the-art particle accelerators, a radiobiologist exploring how those particle beams affect cells and tumors, and a radiation oncologist in clinical practice. The session will also address the questions of how to test the relative efficacy of hadron therapy versus conventional radiation treatment and ethical issues related to clinical trials, how to leverage scientific expertise to bring advances driven by basic research to the benefit of society at large, and potential ways to increase treatment access for patients through cost-saving accelerator designs.

SPEAKERS

Stephen Peggs, Physicist, Brookhaven National Laboratory, Adjunct Professor, Stony Brook University (Advances in Accelerator Science Deliver Precision Beams for Cancer Therapy)

Kathryn Held, Radiation Biologist, Associate Professor of Radiation Oncology, Harvard Medical School; associate radiation biologist, Massachusetts General Hospital (Charged Particles for Cancer Treatment: The Benefits of Ions over Photons)

Hak Choy, Chair, Department of Radiation Oncology at the University of Texas Southwestern Medical Center (The Clinical Perspective: Does Proton/Ion Beam Therapy Work?)

Discussant: Ken Peach, Professor, Particle Therapy Cancer Research Institute at Oxford Martin School, Oxford University

Moderator: James Deye, Program Director, Division of Cancer Treatment and Diagnosis, Radiation Research Program, National Cancer Institute

This session was organized by Karen McNulty Walsh, Media & Communications Office, Brookhaven National Laboratory with Co-Organizers Stephen Peggs, Physicist, Brookhaven National Laboratory, and Eric Colby, Office of Science, U.S. Department of Energy.

For more details, including links to talk summaries, see: http://aaas.confex.com/aaas/2014/webprogram/Session6784.html

Brookhaven Lab's role in this research and this symposium is funded by the DOE Office of Science.

DOE's Office of Science is the single largest supporter of basic research in the physical sciences in the United States, and is working to address some of the most pressing challenges of our time. For more information, please visit science.energy.gov.

One of ten national laboratories overseen and primarily funded by the Office of Science of the U.S. Department of Energy (DOE), Brookhaven National Laboratory conducts research in the physical, biomedical, and environmental sciences, as well as in energy technologies and national security. Brookhaven Lab also builds and operates major scientific facilities available to university, industry and government researchers. Brookhaven is operated and managed for DOE's Office of Science by Brookhaven Science Associates, a limited-liability company founded by the Research Foundation for the State University of New York on behalf of Stony Brook University, the largest academic user of Laboratory facilities, and Battelle, a nonprofit applied science and technology organization.

Karen McNulty Walsh | EurekAlert!
Further information:
http://www.bnl.gov

More articles from Medical Engineering:

nachricht New imaging technique in Alzheimer’s disease - opens up possibilities for new drug development
28.09.2016 | Lund University

nachricht Termination of lethal arrhythmia with light
13.09.2016 | Rheinische Friedrich-Wilhelms-Universität Bonn

All articles from Medical Engineering >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: New welding process joins dissimilar sheets better

Friction stir welding is a still-young and thus often unfamiliar pressure welding process for joining flat components and semi-finished components made of light metals.
Scientists at the University of Stuttgart have now developed two new process variants that will considerably expand the areas of application for friction stir welding.
Technologie-Lizenz-Büro (TLB) GmbH supports the University of Stuttgart in patenting and marketing its innovations.

Friction stir welding is a still-young and thus often unfamiliar pressure welding process for joining flat components and semi-finished components made of...

Im Focus: First quantum photonic circuit with electrically driven light source

Optical quantum computers can revolutionize computer technology. A team of researchers led by scientists from Münster University and KIT now succeeded in putting a quantum optical experimental set-up onto a chip. In doing so, they have met one of the requirements for making it possible to use photonic circuits for optical quantum computers.

Optical quantum computers are what people are pinning their hopes on for tomorrow’s computer technology – whether for tap-proof data encryption, ultrafast...

Im Focus: OLED microdisplays in data glasses for improved human-machine interaction

The Fraunhofer Institute for Organic Electronics, Electron Beam and Plasma Technology FEP has been developing various applications for OLED microdisplays based on organic semiconductors. By integrating the capabilities of an image sensor directly into the microdisplay, eye movements can be recorded by the smart glasses and utilized for guidance and control functions, as one example. The new design will be debuted at Augmented World Expo Europe (AWE) in Berlin at Booth B25, October 18th – 19th.

“Augmented-reality” and “wearables” have become terms we encounter almost daily. Both can make daily life a little simpler and provide valuable assistance for...

Im Focus: Artificial Intelligence Helps in the Discovery of New Materials

With the help of artificial intelligence, chemists from the University of Basel in Switzerland have computed the characteristics of about two million crystals made up of four chemical elements. The researchers were able to identify 90 previously unknown thermodynamically stable crystals that can be regarded as new materials. They report on their findings in the scientific journal Physical Review Letters.

Elpasolite is a glassy, transparent, shiny and soft mineral with a cubic crystal structure. First discovered in El Paso County (Colorado, USA), it can also be...

Im Focus: Complex hardmetal tools out of the 3D printer

For the first time, Fraunhofer IKTS shows additively manufactured hardmetal tools at WorldPM 2016 in Hamburg. Mechanical, chemical as well as a high heat resistance and extreme hardness are required from tools that are used in mechanical and automotive engineering or in plastics and building materials industry. Researchers at the Fraunhofer Institute for Ceramic Technologies and Systems IKTS in Dresden managed the production of complex hardmetal tools via 3D printing in a quality that are in no way inferior to conventionally produced high-performance tools.

Fraunhofer IKTS counts decades of proven expertise in the development of hardmetals. To date, reliable cutting, drilling, pressing and stamping tools made of...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

European Health Forum Gastein 2016 kicks off today

28.09.2016 | Event News

Laser use for neurosurgery and biofabrication - LaserForum 2016 focuses on medical technology

27.09.2016 | Event News

Experts from industry and academia discuss the future mobile telecommunications standard 5G

23.09.2016 | Event News

 
Latest News

New imaging technique in Alzheimer’s disease - opens up possibilities for new drug development

28.09.2016 | Medical Engineering

Innovate coating extends the life of materials for industrial use

28.09.2016 | Materials Sciences

Blockchain Set to Transform the Financial Services Market

28.09.2016 | Business and Finance

VideoLinks
B2B-VideoLinks
More VideoLinks >>>